-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
CymaBay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- CymaBay Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$42.5M, a 81% decline year-over-year.
- CymaBay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$102M, a 9.2% decline year-over-year.
- CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$102M, a 9.2% decline from 2022.
- CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$93.1M, a 6.31% decline from 2021.
- CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$87.6M, a 66.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)